Human Donor Blood for Bioassay Development
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: Aug 03, 2024 11:24 pm EDT
- Original Date Offers Due: Aug 13, 2024 10:00 am EDT
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: Aug 28, 2024
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code:
- NAICS Code:
- Place of Performance: Silver Spring , MD 20903USA
Description
Solicitation Number:75F40124Q00412
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, effective 05/22/2024.
THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE
SOLICITATION WILL NOT BE ISSUED.
The solicitation number for this acquisition is 75F40124Q00412 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 621991. This will be awarded as Firm-Fixed Price as competed as Full and Open. Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.GOV. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary.
The U.S. Food and Drug Administration (FDA) requires a Human Donor Blood for BioAssay Development Delivery.
A. OBJECTIVES/PURPOSE
For the development of bioassays using peripheral blood mononuclear cells (PBMC) and/or isolated immune cells, we require a reliable and steady source of blood products from human donors.
See attached RFQ CB Synopsis Solicitation .
Attachments/Links
Contact Information
Primary Point of Contact
- PATRICIA NATIVIDAD
- PATRICIA.NATIVIDAD@FDA.HHS.GOV
- Phone Number 3017968919